| Item | Content |
|---|---|
| Rating | Neutral |
| Target price | RMB 15–20 (base-case fair-value range, midpoint ~RMB 17.5) |
| Current price | RMB 15.91 (close on 2026-10-29, total share capital 7.039 billion shares, market cap RMB 111.992 billion) |
| Margin of safety | -5.7% (base-case fair-value floor of RMB 15 is below the current price; no positive margin of safety) |
| Probability-weighted expected value | ~RMB 17.45 (+9.7% vs. current price) |
| Time horizon | 12 months |
| Sector lens | Cyclical (refining & chemicals integration + PTA + polyester new materials) |
Hengli Petrochemical's net profit attributable to shareholders for the first three quarters of 2026 was RMB 10.256 billion (+104.2% YoY), already exceeding full-year FY2025 (RMB 7.075 billion); yet the stock is down 27.7% YTD, near its 52-week low (RMB 15.00), with a P/B of 1.50x in roughly the bottom 3% of the past five years. The large divergence between earnings and share price stems from the market's disbelief in the sustainability of current earnings — and that skepticism has substantial grounding: about two-thirds of the total profit increment came from a sharp drop in taxes and surcharges (RMB 4.458 billion less paid YoY) plus FX and crude oil futures investment gains, while consolidated gross profit actually fell slightly by RMB 0.98 billion YoY. The Singapore refining crack of USD 41.6/bbl is significantly above the ten-year midpoint, representing a one-off geopolitical premium.
This report's base case: the geopolitical premium unwinds within H1 2027, but the low tax basis persists; combined with the rare capacity-addition vacuum in PTA/PX/refining in 2027–2028 and "anti-involution" coordination, the 2027 net profit attributable midpoint is RMB 9.5–11.0 billion (above the RMB 6.9–7.1 billion platform of 2023–25, below the 2026 run rate). The current price implies sustainable earnings of roughly RMB 8.0–9.3 billion — nearly identical to pre-conflict sell-side consensus (RMB 8.57–10.1 billion); the market is pricing on "normalized earnings excluding the geopolitical premium," which is internally consistent. The probability-weighted expected value is ~RMB 17.45 (+9.7%), broadly in line with a 9.5% cost of equity: valuation is fair-to-modestly cheap but with no significant margin of safety; rating Neutral. Strategically, below RMB 15 is the re-assessment/add-allocation value zone, above RMB 20 is the take-profit zone, with timing tied to three themes: PTA processing margins, oil prices, and the January 2027 earnings pre-announcement/dividend plan.
Nature of opportunity: fairly-to-modestly cheap + a conditional re-rating option, not an immediate heavy-position signal (evidence grade B). Three verifiable variables determine whether a re-rating can be realized within 12 months: ① whether the geopolitical spread unwinding gets out of control (Brent, Singapore crack, PTA futures discount annualized at -16.3% already prices in part of the unwind); ② whether the PTA processing margin midpoint can hold above RMB 800/ton (currently RMB 859/ton vs. historical average of RMB 756); ③ whether the FY2026 dividend payout ratio can return from 36.8% to above 40% (if so, based on ~RMB 12.4 billion 2026E attributable profit, the dividend yield would be 4.5%–5.1%, triggering a "cyclical earnings + quasi-dividend" re-rating).
The expectation gap is real but not deep. The current price only requires the company to deliver roughly RMB 8.0–9.3 billion in sustainable earnings, whereas the reality is a 2026 run rate of RMB 12.3–13.7 billion, and 9M non-recurring-adjusted profit of RMB 7.898 billion has already exceeded full-year FY2025; however, the base-case fair-value midpoint of RMB 17.5 is only ~+10% above the current price, and after discounting at a 9.5% cost of equity, the excess return is approximately zero. The primary share-price driver is confirmation of the spread midpoint (the tax basis and PTA processing margin); falsification points are equally clear (processing margin below RMB 500/ton, Brent below USD 75/bbl).
Key evidence:
Spread recovery is real (especially in PTA and new materials), and consistently full capacity utilization (FY2025 major units at 100%) means there is no volume elasticity — all earnings improvement depends on spreads and financial line items. But it must be pointed out: the company's "spread-recovery-driven" narrative explains only a bit more than half at the consolidated statement level — stripping out taxes, FX, and futures, more than half of the 2026 apparent doubling is not operating-spread-driven. This structure directly determines the high sensitivity of 2027 apparent profit to "whether the tax basis persists" (see C3), and is one of the core reasons the market assigns a low valuation.
Key evidence:
The supply-side framework holds: zero new PTA capacity in 2026 with effective capacity shrinking, PX additions plunging after concentrated release in H2 2026, refining constrained by the red line, and continued OECD refining shutdowns. But this report must also list three discounts: ① the global picture is not contracting — OECD shutdowns are offset by additions in the Middle East/India/China, and global refining capacity still grows net through 2021–2030 (IEA basis); the "global clearing" narrative only holds for the OECD; ② zero additions ≠ tight supply — existing PTA capacity is ~94.5 million tons with strong incentives to raise operating rates at high processing margins; pre-conflict professional forecasts of the 2026 PTA screen processing margin midpoint were only RMB 250–350/ton, and the divergence from the current RMB 859/ton itself indicates the current spread contains both cyclical and geopolitical premiums; ③ the "9.6 million tons of elimination" is a brokerage estimate rather than a policy document, and actual permanent removal in 2025 was only 4.065 million tons. Overall, this report judges that the 2027 midpoint will be above the 2023–25 platform (base case RMB 9.5–11.0 billion), but with moderate-to-low confidence, to be verified month-by-month via annual spread data from January 2027 onward and coordination discipline.
Key evidence:
The sharp drop in taxes has two possible mechanisms, and the company has never formally explained it: if it reflects a structural "cut fuel, add chemicals" shift (same source as Rongsheng's disclosure), it is sustainable and a lasting positive for earnings; if taxes revert in 2027 to the FY2025 basis (RMB 8.969 billion vs. an annualized ~RMB 5.3 billion in 2026), apparent profit faces base pressure on the order of RMB 3.66 billion/year — even with spreads fully maintained, 2027 apparent profit could post a large YoY decline and be misread by the market as a downturn. Similarly, the Singapore crack of USD 41.6/bbl is significantly above the ten-year midpoint (even the 2022 peak exceeded USD 20), and domestic refiners constrained by export quotas cannot fully benefit directly; its unwinding pace is another major variable for 2027 earnings. Non-recurring items plus taxes together constitute a "high-base trap" for 2026 apparent profit into 2027.
Key evidence:
Under a stress scenario (trough EBITDA ~RMB 15–17 billion), net debt/EBITDA would rise to ~6.5x; debt due within one year ~RMB 93.5 billion vs. deployable cash (~RMB 26.8 billion after restricted deduction; RMB 28.6 billion on a cash-and-equivalents basis), with the gap reliant on rolling financing — 9M "cash received from borrowings" of RMB 87.9 billion indicates bank channels are currently open, and ~RMB 40 billion of short-term borrowings are bill discounts (trade-related, fast-rolling). The capex peak of 2023 (RMB 39.7 billion) is confirmed over, CapEx/depreciation has fallen to 0.57, and construction in progress has been cut from a RMB 48.8 billion peak to RMB 25.7 billion — the "harvest period + deleveraging" capital allocation framework holds. This report concludes: liquidity can withstand a 1–2 year trough, but at the cost of suspended dividends and reduced spending; if falling spreads and tightening financing coincide, rolling refinancing is the single point of failure.
Key evidence:
The current price implies sustainable earnings of roughly RMB 8.0–9.3 billion (back-solved from market cap ÷ 12–14x midpoint) — nearly identical to pre-conflict sell-side consensus (RMB 8.57–10.1 billion): the market prices on "normalized earnings excluding the geopolitical premium," and that earnings level corresponds to ROE of 10.7%–12.4%, exactly the 2023–25 realized range — the pricing is internally consistent; the market is not necessarily wrong. This report's differentiated judgment (2027 midpoint RMB 9.5–11.0 billion) depends on the tax basis persisting and coordination discipline being honored — a moderate-confidence judgment, not fact. Three scenarios: bear RMB 9.5–12.5 (30%), base RMB 15–20 (50%), bull RMB 24–30 (20%); probability-weighted expectation RMB 17.45 (+9.7%) — broadly in line with a 9.5% cost of equity; the upside option (bull scenario +70%) and downside risk (bear scenario -31%) are broadly symmetric, slightly positive. Neither quality (integrated leader, through-cycle ROE ~10.4%, most stable among five peers) nor price (P/B in a historically low zone) is demanding, but it is neither cheap enough to warrant a heavy position, nor is there sufficient catalyst certainty to support an aggressive bet.
| Metric | FY2023 | FY2024 | FY2025 | 2026Q3 Single Quarter | 9M 2026 |
|---|---|---|---|---|---|
| Operating revenue (RMB 100mn) | 2,348.66 | 2,364.01 | 2,010.87 | 528.53 (-1.2%) | 1,510.75 (-4.0%) |
| Net profit attributable (RMB 100mn) | 69.05 | 70.44 | 70.75 | 30.50 (+54.6%) | 102.56 (+104.2%) |
| Non-recurring-adjusted attributable profit (RMB 100mn) | 59.97 | 52.09 | 59.49 | 25.62 (+35.6%) | 78.98 (+88.7%) |
| Gross margin | 11.25% | 9.86% | 13.14% | 12.26% | 13.37% |
| Net margin | 2.94% | 2.98% | 3.52% | 5.77% | 6.79% |
| Operating cash flow (RMB 100mn) | 235.36 | 227.33 | 311.22 | ~157.5 | 192.52 (-4.4%) |
| Free cash flow (RMB 100mn) | -162.05 | 9.18 | 240.11 | — | 146.37 |
| Cash + cash-like assets (RMB 100mn) | — | — | 311.91 (year-end) | — | 433.99 (2026-09-30, incl. ~14.1bn restricted) |
| Interest-bearing debt (RMB 100mn) | 1,511.56 | 1,665.17 | 1,516.40 (year-end) | — | 1,523.27 (2026-09-30) |
| Debt-to-assets ratio | 76.98% | 76.78% | 74.53% | — | 71.88% (2026-09-30) |
| Net debt/EBITDA (x) | 5.86 | 5.59 | 4.65 | — | ~4.3 (annualized estimate) |
| DPS (RMB) | 0.55 | 0.45 | 0.37 (interim 0.08 + final 0.29) | — | — |
Reasons for metric changes (company explanations attached for YoY ≥ ±20%): ① FY2025 revenue -14.93%: company attributes it to the Brent annual average price falling 14.4% YoY driving down selling prices, and crude chemical products trading revenue -36.59% (volume-price and trading contraction, not share loss); ② FY2025 gross margin +3.29pp: crude cost -21.41%, PX cost -14.20%, raw material declines exceeded selling price declines; ③ 9M 2026 attributable profit +104.2%: company attributes it to "improved supply-demand dynamics and recovering prosperity, with significant recovery of refining & chemicals and PTA processing spreads"; this report's decomposition shows the RMB 4.458 billion reduction in taxes and surcharges plus ~RMB 2.7 billion of FX/futures gains contributed more than operating spreads (consolidated gross profit -RMB 0.98 billion YoY); ④ taxes and surcharges 9M YoY -52.82%: not explained by the company (this report judges it related to the industry-wide "cut fuel, add chemicals" production-mix shift, see C3); ⑤ FY2025 operating cash flow +36.90%: company explanation includes a large increase in futures brokerage client deposits (non-core factor); ⑥ 2026H1 operating cash flow -82.03%: company explanation is raw material stockpiling, reduction of oversold volumes and adjusted operating loads, and lower futures margin increments; ⑦ FY2025 capex -67.4%: the spending peak flagged in the 2023 annual report as ending in H2 2024 was realized; ⑧ 2026Q1 inventory +35.8% from year-start: company "bullish on chemical prices, holding inventory to preserve prices"; fell back to RMB 21.2 billion by Q3.
Q3 single-quarter revenue RMB 52.853 billion (-1.2%), attributable profit RMB 3.050 billion (+54.6%, -7.5% QoQ), non-recurring-adjusted RMB 2.562 billion (+35.6%, -12.5% QoQ), gross margin 12.26% (prior-year period 16.36%, a marked YoY decline). Three key readings: ① volume contraction — Q3 external sales of refining & chemicals products of 3.3406 million tons, -39.6% YoY (the company stated explicitly in its semi-annual report that it was "reducing oversold volumes and appropriately adjusting processing loads"); under high oil prices, cutting external sales of low-margin oil products and shifting to chemicals was a proactive choice; ② price support — PTA average price +22.1% YoY vs. PX cost +16.6%, new materials average price +19.6%; spread recovery concentrated in PTA and new materials; ③ profit structure — Q3 single-quarter taxes and surcharges only ~RMB 790 million (prior-year period ~RMB 4.2 billion), this item alone exceeding the Q3 attributable profit increment. For 9M overall: the "apparent doubling" stands (pre-announcement vs. actual error <0.1%, high management forecast credibility), but the QoQ trajectory has declined for two consecutive quarters, and sell-side Q4 implication is ~RMB 2.1–2.3 billion (vs. actual Q4 2025 of RMB 2.052 billion, roughly flat YoY) — the market's pricing of "Q3 as this cycle's single-quarter peak" has its rationale. On whether results beat expectations: there are no comparable publicly available quarterly consensus data; this report anchors on management's pre-announcement range and sell-side full-year forecasts (RMB 11.8–13.6 billion) — 9M fell in the upper half, i.e., in line, at the upper end, not constituting a new upward-revision catalyst.
Business model in brief: An asset-heavy, highly cyclical "oil-coal-chemical integrated" platform — 20 million tonnes/year refining → 4.5 million tonnes PX → 16.6 million tonnes PTA (first tier globally by nameplate capacity) → polyester new materials (filament yarn / industrial yarn / functional films / engineering plastics / biodegradables), supported by 6 million tonnes/year coal chemicals (250,000 tonnes coal-to-hydrogen + 920MW captive power plant) forming a dual-route feedstock hedge. Revenue is entirely cyclical commodity sales, with no subscription/recurring revenue; trading revenue has shrunk to 7.7%. Overall weak pricing power (price taker), but differentiated products (MLCC release films: domestic penetration only 24%) carry relative pricing power; medium-to-strong bargaining power over 20,000 fragmented downstream customers (top five customers only 8.91%).
Cash content of earnings: OCF/net profit of 3.41 (FY23) → 3.23 (FY24) → 4.40 (FY25) → 1.88 (9M26); superficially far above 1, but distorted by inflows/outflows of futures brokerage client margin funds (per the company's own disclosure); excluding this, core operating cash generation is roughly in the 1.5–2x range — healthy. FCF/net profit: -2.35 → 0.13 → 3.39 → 1.43; negative at the 2023 expansion peak, turning sharply positive from 2025 as capex tapers — book profits do convert to cash during the harvest phase. Recurring earnings check: 9M2026 non-recurring gains/losses of RMB 2.358 billion represent 23% of attributable net profit (≥15% threshold), comprising government subsidies of RMB 1.597 billion + disposal/fair-value gains on financial assets of RMB 1.255 billion (pre-tax) — the attributable figure overstates core earnings; the RMB 7.898 billion excluding non-recurring items is the true operating anchor. The company discloses no Non-GAAP reconciliation; the ex-non-recurring figure is the strictest available measure.
Return on capital: FY2025 ROIC of ~4.6% (NOPAT RMB 10.1 billion / invested capital RMB 218.4 billion), below typical WACC (~9.5%) — at the cycle trough, capital returns do not cover the cost of capital, and interest on over RMB 100 billion in net debt consumes the bulk of profit; but through-cycle ROE is ~10.4% (realized 12.2%/11.4%/10.9% over 2021–25), with 2026 TTM ROE recovering to ~16.4%. Capital returns exhibit extreme cyclical elasticity — this is the nature of the business.
Capex quality: CapEx/depreciation of 4.5 (2023) → 1.98 (2024) → 0.57 (2025) → ~0.5 (9M26 annualized); shifting from heavy-capital expansion to primarily maintenance of existing assets. No disclosed split between maintenance vs. growth capex; qualitative assessment: projects under construction are all completions of earlier projects being capitalized (the 1.6 million-tonne high-performance resins project, 800,000-tonne functional films with 7 lines already capitalized, partial capitalization of the 600,000-tonne functional polyester film and lithium battery separator project, and trial production of the 600,000-tonne BDO unit); no new major growth projects. FY2025 technical-upgrade cost savings of ~RMB 1 billion represent maintenance investment. Conclusion: The capex taper is real and directionally correct, but the assumption of "maintenance capex at only ~5% of gross fixed assets per year" is the biggest uncertainty in the EPV calculation.
Red flags and moat: Moat = park-level pipeline integration (lowest-quartile transport/storage/processing costs) + captive power plant and coal-to-hydrogen + licensing and scale barriers; red flags = high leverage (net debt RMB 108.9 billion), controlling shareholder pledge of 18%, non-recurring items at 23%, OCF distorted by non-core factors. No goodwill risk (RMB 77 million); customer/supplier concentration is low and stable.
Word-deed consistency: partially delivered. ① "Capex peak essentially over by H2 2024; focus shifting to operational optimization and debt reduction" (FY2023 annual report) → delivered: CapEx RMB 39.7 → 21.8 → 7.1 → 4.6 billion; interest-bearing debt peaked and declined; ② the accompanying commitment to "strengthen dividends" → not delivered: DPS 0.55 → 0.45 → 0.37 yuan, payout ratio 56.1% → 45.0% → 36.8%, down three consecutive years; ③ spin-off listing of Kanghui New Materials → terminated (August 2024, after a failed attempt in 2022). Earnings pre-announcement accuracy is extremely high (pre-announcement vs. actual gap <0.1%), but annual report language is heavily promotional ("an epic leap") with little quantitative guidance, making accountability difficult. Overall judgment: pragmatic at the execution level, conservative on capital operations and shareholder returns.
Shareholder friendliness: neutral-to-conservative. Cumulative dividends of RMB 9.644 billion over three years (137.6% of average annual net profit — stock-level returns not low), but the marginal trend is deteriorating (absolute dividends RMB 3.87 → 3.17 → 2.60 billion); a RMB 200–300 million buyback launched July 2026 (<0.2% of market cap; RMB 172 million executed by end-September at prices of 15.29–15.84 yuan) is more symbolic than substantive; no refinancing dilution (share count unchanged for years) is a plus. The controlling shareholder added ~RMB 500 million in February 2026 (average price 24.54–25.19 yuan; current price implies ~35% paper loss) — behaviorally endorsing value, but with poor timing.
Risk signals: Deputy GM Huang Xudong resigned in August 2026 (tenure only ~1.5 years); the fifth employee stock ownership plan (subscribed at 18.96 yuan in 2020) extended from 66 to 78 months — employees underwater and plan extended; investors previously questioned possible insider trading given share-price moves before the earnings pre-announcement (company denied; no regulatory inquiry seen); controlling shareholder pledge at 18% (on a declining trend).
| Segment | Revenue share | Gross margin | GM YoY | Revenue YoY | One-line business logic |
|---|---|---|---|---|---|
| Refining & chemical products | 47.5% | 20.91% | +7.78pp | -12.81% | Profit engine: 20 Mt refining integration + refined oil/aromatics; subsidiary Hengli Refining FY2025 net profit RMB 5.478 billion |
| PTA | 28.8% | 4.83% | +1.44pp | -16.00% | First tier globally by capacity (16.6 Mt); a commodity processing business recovering from trough spreads |
| Polyester products | 20.1% | 7.35% | -6.76pp | -4.29% | Top five in filament yarn / global No.1 in industrial yarn; gross margin fell sharply from 14.11% amid intensifying competition |
| Others (incl. trading) | 3.6% | 8.68% | — | -55.28% | Trading actively shrunk (-36.59%) |
Profit engine estimate: By revenue share × gross margin, refining contributes ~76% of core gross profit (9.9/13.1), PTA and polyester ~10% each — the profit engine is refining and aromatics, not the combined processing segments with larger revenue shares; this structure strengthened further in 2026 (Hengli Refining contributed RMB 4.6 billion net profit in H1). The 16.1pp gross margin gap (refining 20.91% vs. PTA 4.83%) must be explained: the refining segment enjoys integrated refined oil/aromatics spread benefits and dual oil/coal feedstock flexibility, while PTA is an oversupplied, fiercely competitive commodity processing segment — the bargaining-power difference on the same value chain between the "resource + license" segment and the "processing" segment. Note a 2026 reporting change: quarterly operating data now groups downstream products as "new materials products" (9M revenue RMB 33.305 billion, sales volume 3.9875 million tonnes, average price +19.6% — the only segment with both volume and price gains); the boundary between polyester and new materials is being reclassified — watch definitions when tracking.
Accounting red flags: ① Taxes and surcharges (consumption tax) swinging widely by ±RMB 2.5 billion with no explanation in MD&A (FY2022–9M2026: 66.3 → 92.0 → 64.2 → 89.7 → 39.8 billion; severity: medium) — a line item directly affecting one-third of pre-tax profit with no disclosed basis; this is the report's largest information asymmetry; ② rising share of non-recurring items (9M2026: 23% of attributable profit; Q1 alone booked RMB 1.5 billion of non-recurring gains; severity: medium); ③ operating cash flow includes futures brokerage client margin funds (FY2025 inflated OCF/net profit to 4.4x, reversed in 2026; severity: medium); ④ Q1 stockpiling of RMB 8.5 billion on bullish expectations (a price reversal would convert into inventory losses; severity: low — RMB 865 million of asset impairments already provisioned over 9M); ⑤ large restricted assets (RMB 106.6 billion, including RMB 14.1 billion restricted cash; severity: low).
Cross-period consistency: ① Taxes and surcharges — multi-period data as above, unexplained by the company (inconsistency); ② OCF/attributable net profit 3.41 → 3.23 → 4.40 → 1.88 — the company's explanation is consistent across periods (margin fund factor; "consistent" item); ③ gap between attributable and ex-non-recurring profit (non-recurring items 9.1/18.4/11.3/23.6 billion yuan) — unexplained by the company. Overall: two "company-unexplained" cross-period anomalies and three medium-severity red flags found; no evidence of systematic fraud (consecutive standard unqualified audit opinions, precisely delivered pre-announcements, near-zero goodwill), but earnings "predictability" is genuinely poor — this is both the source of the valuation discount and the key focus for the next tracking phase (once the tax basis becomes clear, the expectation gap should converge).
Current market data and percentile (close 2026-10-29: 15.91 yuan): Market cap RMB 111.992 billion; PE(TTM) 9.1x (TTM attributable profit RMB 12.308 billion; ~6th percentile over 5 years — during a cyclical upswing, earnings are on the rising leg, so mechanically low PE percentiles are reference only); static PE (FY2025) 15.83x (~55th percentile over 5 years; closest to a normalized basis); PB 1.50x (~lowest 3rd percentile over 5 years; 5-year median 1.88, 10-year median 2.66); dividend yield ~2.3% (FY2025 full year 0.37 yuan; 1.8% on TTM basis). For cyclicals the primary anchor is PB×ROE: through-cycle ROE ~10.4%; at a 9.5% cost of equity, a zero-growth fair PB is ~1.09, or ~1.5–1.7 including growth — the current 1.50 sits mid-range.
Peer comparison (2026-10-29):
| Company | PE(TTM) | PB | ROE (latest period) | Key difference |
|---|---|---|---|---|
| Hengli Petrochemical | 9.1 | 1.50 | 16.4% (TTM) / 10.4% (through-cycle) | Strongest integration and earnings stability of the five |
| Rongsheng Petrochemical | 15.2 | 2.31 | 16.7% (9M26; FY25 only 1.9%) | Zhejiang Petrochemical's 40 Mt is larger; only private exporter with quotas, but weaker through-cycle stability |
| Eastern Shenghong | 15.7 | 1.92 | 12.7% (9M26; FY25 0.4%, ex-non-recurring loss) | EVA/POE photovoltaic new materials elasticity; highest debt ratio at 79.6% |
| Tongkun Group | 9.5 | 1.16 | 5.4% (FY25) | Pure-play filament leader; half of profit from Zhejiang Petrochemical equity income |
| Xin Feng Ming | 10.1 | 1.21 | 5.8% (FY25) | PTA-filament midstream integration; gross margin only 5–8% |
Market-implied expectations: At the current price, the market requires ~RMB 8.0–9.3 billion/year of sustainable earnings (back-solving from a 12–14x central multiple), whereas reality is a 2026 run rate of RMB 12.3–13.7 billion and a 2023–25 plateau of RMB 6.9–7.1 billion — the market is pricing in "normalized earnings after geopolitical and spread windfalls fully fade," which coincides with pre-conflict sell-side consensus (RMB 8.57–10.1 billion), implying roughly zero long-term growth. Two-way check: if the 2027 supply gap lifts the midpoint to RMB 9.5–11.0 billion, the implied expectation is ~15%–25% too low; if tax reversals plus spread mean-reversion bring RMB 6.0–9.5 billion, the implied expectation is exactly right. This is the mathematical expression of the bull-bear divide — the disagreement is not asset quality but the 2027 earnings midpoint.
Three-layer value (EPV): ① Asset value (floor): replacement-cost basis ~15.5 yuan/share (fixed assets RMB 145.4 billion + construction in progress RMB 25.7 billion × 20–40% replacement uplift; independently estimated, not added to EPV); book BVPS 10.64 yuan; ② EPV zero growth: 14.74 yuan/share (basis=equity: sustainable FCFE 1.40 yuan/share ÷ 9.5% cost of equity; normalized base = 2021–2025 full-cycle attributable mean of RMB 7.774 billion, bridge = attributable profit + D&A of 12.456 billion − steady-state CapEx of 10.38 billion − working capital ≈ 0 → FCFE ~RMB 9.85 billion; range 11.6–21.3 yuan); ③ Growth option: current price − EPV ≈ 1.17 yuan, ~7.4% of current price (back-filled using the system's standardized calculation) — the market is essentially paying only for zero growth, with less than a tenth of the price for "2026–27 upcycle exceeding normalization + new materials ramp." For a cyclical in recovery, zero-growth EPV is a floor, not a ceiling: if the 2027 midpoint of RMB 9.5–11.0 billion materializes, value lies above 17.5 yuan — whether that option deserves payment depends on scenarios, not the EPV residual.
Three scenarios and odds (12 months):
| Scenario | Probability | Fair range | Midpoint | vs. current price | Key swing factor |
|---|---|---|---|---|---|
| Bear | 30% | 9.5–12.5 yuan | 11.0 yuan | -31% (range -40% to -21%) | Tax base reversal (-3.66 billion/year) + full giveback of geopolitical premium + weakening filament demand; 2027E attributable profit RMB 6.5–7.5 billion × 10–11.5x (PB 0.9–1.2x, approaching the 2024 cycle bottom) |
| Base | 50% | 15–20 yuan | 17.5 yuan | +10% (range -6% to +26%) | Geopolitical premium gives back in 2027H1, low tax basis persists, supply gap provides support; 2027E attributable profit RMB 9.5–11.0 billion × 11–13x (PB 1.4–1.9x, comparable to the 5-year median) |
| Bull | 20% | 24–30 yuan | 27.0 yuan | +70% (range +51% to +89%) | Geopolitical premium persists + PTA spread holds at 850 yuan/tonne + new materials volume and margin both rise; 2027E attributable profit RMB 13.0–15.0 billion × 13–15x (≈ sell-side consensus path; median target price 26 yuan) |
Basis for base-case exit multiple (independent of the company's current price): The 11–13x takes the middle of three anchors — ① peer median TTM PE of 12.6x (computed 2026-10-29); ② EPV zero-growth implied ceiling of ~10.5–11.6x (EPS 1.10 yuan ÷ 9.5% cost of equity); ③ the company's own 5-year median PE of 14.0x is systematically inflated by trough earnings in 2022–24; the true mid-cycle midpoint should be lower — hence 12x as midpoint ±1x; the company's current 9.1x is for reference only. Bear-case anchor note: the most pessimistic externally available sell-side anchor (an April 21, 2026 note implying 2026E/2027E attributable profit of ~10.1/10.6 billion yuan, target price 26 yuan) is in fact a "no-geopolitical-premium normal" basis, milder than this report's bear case and not directly comparable; stress-case math (PB 1.1–1.2x → 11.7–12.8 yuan) overlaps the upper end of this bear case and is used as a reference.
Our earnings forecast vs. third parties (reconciliation anchor):
| Basis | FY2026E attributable profit | FY2027E attributable profit |
|---|---|---|
| This report (base) | RMB 11.8–13.0 billion (ex-non-recurring RMB 9.5–10.6 billion) | RMB 9.5–11.0 billion (range RMB 6.5–15.0 billion, depending on taxes and spreads) |
| Sell-side consensus (n=22) | RMB 12.565 billion | RMB 14.782 billion |
| Management guidance | No quantitative target (9M of 10.256 billion yuan per the pre-announcement already delivered) | — |
This report's 2027E is ~26%–36% below sell-side consensus: the core disagreement is the persistence of the tax basis (generally not broken out in sell-side models) and the magnitude of geopolitical premium giveback. Methodology note: 9M actuals extrapolation + itemized spread assumptions; the decomposition finding that ~2/3 of incremental profit comes from taxes and FX/futures gains/losses has led this report to significantly widen the 2027E range.
Conclusion: Valuation is reasonably low; target price range 15–20 yuan (base-case fair value); margin of safety -5.7% (base-case fair value floor below current price). Quality and price are separate matters: quality is first-tier among A-share private refiners (through-cycle ROE ~10.4%, most stable of the five); at PB in the lowest historical percentile, pricing is not demanding; but the probability-weighted expected return of +9.7% is roughly on par with the 9.5% cost of equity — no excess return, and the 2.3% dividend yield limits the reward for waiting.
Industry size. The industry boundaries of Hengli's "private refining & chemicals + polyester chain": upstream connected to globally priced crude oil (Brent Q2 2026 average $96.7/bbl, Q3 average $91.3/bbl, elevated by geopolitical conflicts), downstream connected to textiles/apparel, packaging and automotive end markets. Scale metrics (official and association sources): China's primary crude processing capacity was 955 million tonnes at end-2024 (Fitch; government red line 1 billion tonnes), approximately 973 million tonnes at end-2025 (broker estimate), with only ~15 million tonnes under construction in 2026–27; PTA capacity was 86.015 million tonnes in 2024 (China Petrochemical Report), with 8.5 million tonnes added in H2 2025 (Guotai Junan Futures) to approximately 94.5 million tonnes, zero additions in 2026 and effective capacity approximately -1.7% (due to long-term shutdowns/exits); chemical fiber output was 74.75 million tonnes in 2024 (+8.8%, China Chemical Fibers Industry Association), of which polyester accounted for more than 80%; nominal polyester filament capacity was approximately 46.85 million tonnes (July 2026, Baichuan Yingfu). Nature of growth: demand-side low single digits (PTA apparent consumption growth has fallen from 18.5% in 2023 to approximately 3% in 2025; chemical fiber future annual average approximately 4–5%), the industry has entered a stage of "near-zero total volume growth + market clearing" — this round of profitability improvement relies on spreads rather than volume growth, which is the premise for understanding the nature of the 2026 upcycle. Structural demand inflection point self-check: downstream textile/apparel, packaging and refined oil products are all mature end markets; new materials (functional films/lithium battery separators/biodegradable materials) represent the company-level second curve but are small in scale (the new materials segment including conventional civil filament accounts for approximately 21% of revenue), with no evidence of a "step-change in unit consumption" — the demand inflection framework is not triggered; this round is a supply-driven cyclical recovery.
Industry chain and value distribution. Crude oil → refining & chemicals (refined products + chemicals) → aromatics (PX) → PTA → polyester (filament/film/chips) → weaving/textile-apparel end markets; the coal chemical branch (coal-to-hydrogen/captive power) forms a raw material hedge. Gross margin distribution (2025–2026, Hengli basis): refining segment gross margin 21% (+8pp) > polyester 7% (-7pp) > PTA 5% (+1pp); in 2026 profits further concentrate in refining/aromatics — PX-naphtha spread Q3 average $313/t, Singapore refining complex margin reached $41.6/bbl in Q3 (extreme highs). Gross margin is mainly retained in the refining + aromatics segment, and Hengli happens to be the most vertically integrated player across the whole chain (the first to connect "crude oil–aromatics/olefins–PTA/MEG–polyester new materials," with park pipeline coupling reducing costs); bargaining power against upstream crude is weak (globally priced), while bargaining power against 20,000 fragmented downstream customers is moderately strong and strengthens as concentration rises.
Supply-demand and competitive landscape. Demand side: textile/apparel exports were $301.1 billion in 2024 (+2.8%), with US tariff disruptions in 2026; weak recovery of domestic demand (weaving operating rate 57% in June 2026, -13pp YoY; filament operating rate 74.85%, -14.1pct YoY; POY inventory 26.5 days, +62% YoY at historic highs) — a divergent pattern of tight upstream and loose downstream, with the upcycle transmission from top to bottom incomplete. Supply side: ① PTA: zero additions in 2026, effective capacity approximately -1.7%, coordinated production cuts by leaders since October 2025, CR5 approximately 70% (Industrial Securities basis: Hengli 16.6 + Yisheng system 21.5 + Tongkun/Xinfengming system, etc.); ② PX: approximately 4.1–5 million tonnes of additions in 2026 concentrated in H2 (Huajin Aramco 2 million tonnes in October + Yulong Island 3 million tonnes in December; Dadi Futures basis 4.1 million tonnes including Fujia/Jiujiang, with list discrepancies), dropping sharply to 4/2.2 million tonnes in 2027–28 (Huachuang estimate); ③ filament: only 1.61/1 million tonnes of new capacity in 2026H2/2027, 6.15 million tonnes of capacity over 20 years old awaiting elimination; ④ refining: reduction replacement within the 1-billion-tonne red line, only 15 million tonnes under construction in 2026–27; ⑤ Overseas: OECD refining capacity continues to shut down (US over 2 million bbl/d in ten years, Europe processing volume to fall again 2023–30), but on a global basis this is offset by additions in the Middle East/India/China, still net growth (IEA: approximately 101.9 in 2021 → 104.2 in 2024 → 107.4E in 2030 million bbl/d) — "global clearing" only holds for the OECD, and this report has accordingly down-weighted the supply narrative. Entry barriers: policy licenses (red line/crude import quotas/export quotas) + capital (RMB 70 billion-level investment for a 20-million-tonne project) + integration technology, constituting high barriers. Competitive dynamics: after a brutal price war from 2021–2025, the MIIT symposium in October 2025 launched "anti-involution," and in 2026 polyester filament production cuts deepened to 30% and became institutionalized — competition shifting from market-share warfare to coordinated price protection, the sustainability of coordination discipline is the biggest industry variable for 2027 (historically, self-discipline tends to loosen after processing margin recovery; the 94.5 million tonnes of existing capacity has strong incentives to raise utilization). Substitution threats: new energy vehicles substituting gasoline (the main variable for peak refined product demand), marginal substitution by recycled PET; the main chain has no like-for-like substitute.
Cycles and regulation. The industry is in the early-to-mid stage of an upcycle after the 2021–2025 downturn/bottoming, with drivers being supply-side rather than demand prosperity. Policy direction clearly favors the industry structure: the 1-billion-tonne refining red line, the seven-ministry "Stable Growth Plan" strictly controlling new PX/ethylene capacity, "anti-involution" coordinated production cuts, energy-efficiency constraints eliminating outdated capacity; risk side: trend tightening of refined oil export quotas (59 million tonnes in 2020 → approximately 32 million tonnes in 2025; the third batch of 2026 -48.8% YoY, Reuters 2026-10-09), suppressing refiners' main channel for adjusting excess output — note that Hengli is not a recipient of private-enterprise export quotas (in 2025 only Zhejiang Petrochemical among private firms received 3.47 million tonnes), so quota tightening is an indirect suppression for it rather than a direct hit.
Peer benchmarking (operating basis). See E6 valuation benchmark table; operating scale supplement: Rongsheng 2025 revenue RMB 308.6 billion (attributable net profit only RMB 848 million; Zhejiang Petrochemical 40 million tonnes largest single site + PX 10.4 million tonnes No.1 nationally); Eastern Shenghong RMB 125.6 billion (attributable net profit RMB 134 million, non-recurring -RMB 543 million; EVA 900,000 tonnes largest globally); Hengyi RMB 113.5 billion (Brunei 8-million-tonne overseas refinery, Phase II 12 million tonnes expected by end-2028); Tongkun RMB 93.9 billion (filament 15.1 million tonnes No.1 globally, market share 28%+); Xinfengming RMB 71.6 billion (only company with positive revenue growth in 2025, +6.66%, ROE 5.76%). Attributable net profit for the first three quarters of 2026: Hengli RMB 10.256 billion, ranking first among the five (Hengyi RMB 8.011 billion, Rongsheng guidance RMB 7.8–8.2 billion, Shenghong/Tongkun relying on investment income and elasticity) — the profitability resilience gap is amplified in downturns, and moves in the same direction in upturns.
Company industry positioning. Leader: the most integrated and most stable cyclical earner among private large-scale refining & chemical companies. Dual-basis market share (must be presented side by side): ① PTA — company self-built 16.6 million tonnes, approximately 17.5% of the national 94.5 million tonnes of capacity (third-party capacity basis); the company/brokers claim to be the "world's largest PTA supplier," but on a participation/holding nominal capacity basis, the Yisheng system (Rongsheng + Hengyi JV) at 21.5 million tonnes (approximately 22.7%) exceeds Hengli — "world's largest" is contested, depending on self-built vs. participation/holding; ② refining 20 million tonnes approximately 2.1% of national total; ③ PX 4.5 million tonnes approximately 10% of national total (less than Zhejiang Petrochemical's 10.4 million tonnes); ④ filament is not a scale leader (Tongkun/Xinfengming dominate civil filament); Hengli differentiates via industrial filament, functional films, and engineering plastics. Share trend: under anti-involution and coordinated production cuts, leading position is strengthened, with filament share stabilizing rather than expanding. Moat: oil-coal-chemical four-cluster park pipeline coupling + captive power plant/coal-to-hydrogen + "oil where oil suits, aromatics where aromatics suit" flexible switching + full-chain smoothing of single-segment spread volatility.
Cycle positioning (historical template). Three rounds of cycles using Hengli attributable net profit as a mirror: ① 2019–2021 upcycle (large refining capacity launch dividends + post-pandemic demand), 2021 peak approximately RMB 15.5 billion; ② 2022 crash (Brent average $101 +43% + demand stagnation), attributable net profit RMB 2.318 billion (-85%, completed within one year, non-recurring only RMB 1.045 billion); ③ 2023–2025 low plateau (approximately 4 years): attributable net profit RMB 6.9–7.1 billion, non-recurring RMB 5.2–6.0 billion, meanwhile large-scale PTA expansion compressed processing margins to a trough of <RMB 200/t in 2025; ④ 2026 upcycle (in progress, 9 months): triggers = OECD refining shutdowns + domestic red line + anti-involution + geopolitics pushing up oil prices, first three quarters attributable net profit RMB 10.256 billion. Historical pattern: single-round amplitude ±80–90%, downcycle lasting 3–4 years. Current indicator percentiles (October 2026, basis noted): PTA processing margin RMB 859/t (13.6% above the historical mean of 756, upper-middle percentile, just crossed the mean); PX-naphtha $313/t (still ~17% below the historical mean of 376, lower-middle percentile but with a large YoY recovery); Singapore complex margin $41.6/bbl (extreme highs, dominated by a one-time geopolitical premium); PTA operating rate recovered after 63% in May (a six-year low); filament operating rate 74.85% and POY inventory 26.5 days at historical lows/highs; PTA futures backwardation (front-to-back -9.5%, annualized -16.3%) — the commodity market has itself already priced in processing margin giveback. Overall: upstream indicators at "extreme highs + above mean," downstream at "low operating rate + high inventory" cold percentiles, while the stock price (PB near a 5-year low, approximately top 3% percentile) has already priced in a pullback — the mismatch between the earnings cycle and the price cycle is the core feature of this round.
Supply response pace. Certainty ranking over the next 2–3 years: PX 2026Q4 Huajin Aramco (October) + Yulong Island (December) totaling 4.1–5 million tonnes landing — the last bulk supply shock of this cycle, pressuring PXN through 2026Q4–2027H1; thereafter approximately 4 million tonnes in 2027 and approximately 2.2 million tonnes in 2028 (Huachuang basis), plus the Indonesia Tycoon project earliest after 2028, 2027–2028 constitutes a supply vacuum window rarely seen in the past decade. PTA zero additions + elimination of outdated capacity; filament essentially no additions before 2028; refining reduction replacement within the red line; the only certain new large refining project is Hengyi Brunei Phase II (end of 2028). Conclusion: if the geopolitical premium is given back in 2026H2, the supply-side logic remains a second pillar supporting the 2027 earnings center — provided coordination discipline holds (existing capacity raising utilization is the main hedge risk).
Through-cycle earnings. Normalized (mid-cycle) EPS: full cycle (2021–2025) attributable mean RMB 7.774 billion → EPS RMB 1.10 (non-recurring mean RMB 6.544 billion → 0.93; 2023–25 plateau mean RMB 7.008 billion → 1.00); normalized P/E taken at a 12x midpoint (±5x): RMB 7.7–18.8 (midpoint 13.3) — current price 15.91 falls in the upper-middle of this range; trough EPS: 2022 actual earnings trough attributable net profit RMB 2.318 billion → EPS RMB 0.33 (non-recurring 0.15; note: the stock price trough occurred at 2024 PB of 1.46x — price trough ≠ earnings trough). The current TTM PE of 9.1x is of "mid-recovery from trough" nature — neither a low PE at peak (earnings are still recovering) nor a high PE at trough; mechanical application would mislead. Sensitivity of conclusions to the normalized ±5x range (RMB 7.7–18.8): if the market assigns only a normalized 10x or below (implying a normalized ROE center falling below 10%), fair value drops below RMB 11, approaching the bear case; at 14x (5-year median), fair value is RMB 15.4, roughly equal to the current price — the normalized multiple implied by the current price is approximately 14.4x, near the historical midpoint, neither cheap nor expensive. Asset value floor: replacement cost approximately RMB 15.5/share, book value RMB 10.64/share.
Downside stress test. Mean reversion scenario (12 months, geopolitical easing + spreads reverting to mean: Singapore margin → approximately $10, PTA processing margin → approximately RMB 500, PXN → approximately $250): revenue -5%~-8%, EBITDA falls from approximately 30–33 billion (2026E) to 23–25 billion (-25%~-30%), attributable net profit approximately RMB 9–9.5 billion (-25%~-30% vs 2026E consensus). Trough scenario (complete geopolitical easing + demand recession + oil price falling to $60–65 triggering inventory writedowns): attributable net profit RMB 2–3.5 billion (EPS 0.28–0.50, benchmarked against 2022 actual of 2.318 billion — PTA coordination floor and new materials increments make the trough better than 2022's depth), EBITDA approximately 15–17 billion (approximately 40% below the 2023–25 normal level of approximately 27 billion, a stress assumption), net debt/EBITDA rising to approximately 6.5x; trough stock price at PB 1.1–1.2x approximately RMB 11.7–12.8 (-20%~-27% from current price), overlapping the upper end of this report's bear case range (RMB 9.5–12.5). Whether liquidity can survive: it can survive 1–2 years, at the cost of halting dividends and cutting capex to 6–7 billion/year; operating cash flow at trough remains positive (approximately 12–15 billion/year), approximately 40 billion of short-term borrowings are bill discounts (fast rollover), and 9M borrowings obtained of 87.9 billion show smooth credit access; it cannot survive extreme scenarios beyond 3 years (would require group-level asset disposals for support).
Management cycle discipline. Capex peaked in 2023 (39.7 billion) and has declined continuously since, with construction-in-progress reduced from 48.8 → 25.7 billion — better expansion discipline than peers still adding leverage; buybacks launched at 52-week lows (0.2–0.3 billion, relatively small), controlling shareholder increased holdings in February 2026 (a relatively high timing point, now down 35% on paper) — direction is countercyclical, but magnitude and timing both discounted; dividends have contracted with declining earnings (56%→45%→37%), showing no countercyclical stable returns. Overall judgment: good spending discipline, weak shareholder-return discipline, neutral-to-countercyclical.
Overall rating: Neutral (confidence 0.52, 12-month horizon). Hengli Petrochemical is the highest-quality asset among A-share private large-scale refining & chemical companies: highest integration, running at full capacity, through-cycle ROE approximately 10.4%, capex peak has passed, free cash flow has turned positive with deleveraging. But the current price (RMB 15.91, PB near a 5-year low, approximately top 3% percentile) does not correspond to "mispricing" — the market is pricing on normalized earnings excluding geopolitical premium (8–9.3 billion), almost identical to pre-conflict sell-side consensus; pricing is self-consistent. This report's differentiated view of a 2027 midpoint of 9.5–11 billion relies on two variables — the tax line's continuation and anti-involution discipline — neither yet officially confirmed. Probability-weighted expected return +9.7%, roughly equal to the cost of equity; margin of safety is negative — reasonably priced but on the low side; not worth chasing higher, nor reason for panic.
Strategy: Below RMB 15 (baseline fair value floor) as a reassessment zone offering incremental allocation value (at that point one must confirm it is a mispricing rather than the bear scenario materializing); above RMB 20 (baseline fair value ceiling) as a valuation repair realization zone. Position-building/adding pace is tied to three verifiable threads: ① PTA spot processing margin weekly (sustaining above RMB 800/t confirms a rising center; falling below RMB 500/t invalidates the base case); ② Brent price (falling below $75/bbl = signal of complete geopolitical premium giveback); ③ FY2026 earnings pre-announcement and annual dividend plan by end of January 2027 (attributable net profit ≥ RMB 11.8 billion with a payout ratio ≥40% as the re-rating trigger).
Risk disclosures (written summary): Tax and surcharge line reversion causing a large apparent negative growth in 2027 profits and being misread; Singapore refining margin/PTA processing margin mean-reverting faster than expected after geopolitical easing; demand falsification via high polyester filament inventory + low weaving operating rates; continued tightening of refined oil export quotas; PB discount on the hundred-billion net debt amplifying on earnings downgrades; chain risk of controlling shareholder's 18% pledge at lower stock price levels; employee stock ownership plan expirations and selling, plus accumulating governance signals (executive resignations, insider trading questions).
Tracking checklist (summary): Invalidation conditions — PTA processing margin weekly average below RMB 500/t, Brent below $75/bbl, FY2026 attributable net profit below RMB 10 billion, 2027 tax line reverting to an annualized level above 8 billion, net debt/EBITDA rising above 5.5x, pledge ratio rising above 20%, loom operating rate persistently below 50%. Catalysts — FY2026 earnings pre-announcement and dividend plan (by 2027-01-31), PTA processing margin center, Yulong Island PX launch, first batch of 2027 refined oil export quotas, progress on buybacks and insider purchases, stock price touching the RMB 15/20 boundaries.
Price and valuation data in this report are as of the 2026-10-29 close (RMB 15.91); financial data as of the 2026 Q3 report (2026-09-30); industry and spread data as of late October 2026, with bases noted in the text.